Hapni is an online medical platform that provides a rapid, free screening test for sleep apnea, followed by a home-based diagnostic assessment using a portable polygraph device. The service connects patients with sleep specialists for teleconsultations, ensuring timely diagnosis and treatment options that are fully reimbursed by health insurance.
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals with sleep apnea remain undiagnosed, leading to increased risks of stroke, cardiovascular issues, and impaired quality of life due to chronic fatigue. Traditional sleep apnea diagnosis often involves lengthy waiting times for specialist appointments and overnight stays in sleep clinics, creating barriers to timely assessment and treatment.
Solution
Hapni offers a comprehensive online platform for the rapid screening and diagnosis of sleep apnea. Users complete an initial online questionnaire, developed with sleep specialists, to assess their risk level. Individuals identified as high-risk receive a home-based diagnostic assessment using a portable polygraph device to monitor sleep patterns. The collected data is then analyzed remotely by sleep physicians, who conduct teleconsultations with patients to discuss results and prescribe appropriate, insurance-reimbursed treatment plans, such as continuous positive airway pressure (CPAP) therapy.
Target Audience
Hapni primarily targets individuals experiencing symptoms of sleep apnea, such as snoring, daytime fatigue, and difficulty concentrating, as well as those seeking a convenient and accessible alternative to traditional sleep clinic evaluations.
Features
- Online screening questionnaire for initial sleep apnea risk assessment
- At-home sleep diagnostic test using a portable polygraph device
- Remote data analysis by certified sleep physicians
- Teleconsultations for results interpretation and treatment planning
- Prescription of reimbursed therapeutic solutions, including CPAP devices
- Integration with the French national health insurance system (Sécurité Sociale) for reimbursement of diagnostic and treatment costs